Journal article

Role of prednisolone treatment in severe Mycoplasma pneumoniae pneumonia in children

KY Lee, HS Lee, JH Hong, MH Lee, JS Lee, D Burgner, BC Lee

Pediatric Pulmonology | WILEY | Published : 2006


Mycoplasma pneumoniae pneumonia (MP) is responsible for 10-40% of cases of pediatric community-acquired pneumonia. Occasionally, progression to severe pneumonia occurs despite appropriate antibiotic therapy. We retrospectively evaluated the effect of prednisolone in 15 children with MP whose clinical and radiographic course worsened despite broad-spectrum antibiotics, including appropriate macrolides. The mean ( +/- SD) age was 6.1 +/- 1.9 years, and 10 were boys. All children had received macrolides at presentation, but they had persistent fever and progressively worsening radiographic findings. In addition to broad-spectrum antimicrobial therapy, we added prednisolone (1 mg/kg for 3-7 days..

View full abstract